» Articles » PMID: 20385813

A Feed-forward Loop Amplifies Nutritional Regulation of PNPLA3

Overview
Specialty Science
Date 2010 Apr 14
PMID 20385813
Citations 168
Authors
Affiliations
Soon will be listed here.
Abstract

The upsurge in prevalence of obesity has spawned an epidemic of nonalcoholic fatty liver disease (NAFLD). Previously, we identified a sequence variant (I148M) in patatin-like phospholipase domain-containing protein 3 (PNPLA3) that confers susceptibility to both hepatic triglyceride (TG) deposition and liver injury. To glean insights into the biological role of PNPLA3, we examined the molecular mechanisms by which nutrient status controls hepatic expression of PNPLA3. PNPLA3 mRNA levels, which were low in fasting animals, increased approximately 90-fold with carbohydrate feeding. The increase was mimicked by treatment with a liver X receptor (LXR) agonist and required the transcription factor SREBP-1c. The site of SREBP-1c binding was mapped to intron 1 of Pnpla3 using chromatin immunoprecipitation and electrophoretic mobility shift assays. SREBP-1c also promotes fatty acid synthesis by activating several genes encoding enzymes in the biosynthetic pathway. Addition of fatty acids (C16:0, C18:1, and C18:2) to the medium of cultured hepatocytes (HuH-7) increased PNPLA3 protein mass without altering mRNA levels. The posttranslational increase in PNPLA3 levels persisted after blocking TG synthesis with triascin C. Oleate (400 muM) treatment prolonged the half-life of PNPLA3 from 2.4 to 6.7 h. These findings are consistent with nutritional control of PNPLA3 being effected by a feed-forward loop; SREBP-1c promotes accumulation of PNPLA3 directly by activating Pnpla3 transcription and indirectly by inhibiting PNPLA3 degradation through the stimulation of fatty acid synthesis.

Citing Articles

Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies.

Dileo E, Saba F, Parasiliti-Caprino M, Rosso C, Bugianesi E Nutrients. 2025; 17(3).

PMID: 39940335 PMC: 11821005. DOI: 10.3390/nu17030477.


Identification of Interactive Genetic Loci Linked to Insulin Resistance in Metabolic Syndrome-An Update.

Elfaki I, Mir R, Elnageeb M, Hamadi A, Alharbi Z, Bedaiwi R Medicina (Kaunas). 2025; 61(1).

PMID: 39859066 PMC: 11767019. DOI: 10.3390/medicina61010083.


Cumulative Burden of Fatty Liver and Kidney Cancer in Young Men: A National Population-Based Study.

Lee H, Han K, Kwon H J Clin Med. 2025; 14(1.

PMID: 39797231 PMC: 11721000. DOI: 10.3390/jcm14010148.


Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Pei Y, Goh G Gut Liver. 2025; 19(1):8-18.

PMID: 39774124 PMC: 11736312. DOI: 10.5009/gnl240407.


Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease.

Ahmed O, Shavva V, Tarnawski L, Dai W, Borg F, Olofsson V J Intern Med. 2024; 297(1):47-59.

PMID: 39560367 PMC: 11636427. DOI: 10.1111/joim.20032.


References
1.
Sztalryd C, Kraemer F . Regulation of hormone-sensitive lipase during fasting. Am J Physiol. 1994; 266(2 Pt 1):E179-85. DOI: 10.1152/ajpendo.1994.266.2.E179. View

2.
Tian C, Stokowski R, Kershenobich D, Ballinger D, Hinds D . Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet. 2009; 42(1):21-3. DOI: 10.1038/ng.488. View

3.
Mangan S, Alon U . Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci U S A. 2003; 100(21):11980-5. PMC: 218699. DOI: 10.1073/pnas.2133841100. View

4.
Galliard T . The enzymic deacylation of phospholipids and galactolipids in plants. Purification and properties of a lipolytic acyl-hydrolase from potato tubers. Biochem J. 1971; 121(3):379-90. PMC: 1176584. DOI: 10.1042/bj1210379. View

5.
Horton J, Goldstein J, Brown M . SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002; 109(9):1125-31. PMC: 150968. DOI: 10.1172/JCI15593. View